Anita Fletcher, MD | Appointed by NKGen as National Principal Investigator for Phase 2a Troculeucel Trial

In our latest Clinician’s View, Dr. Patel shares his team’s telesurgery journey, including how they are ensuring safety, quality and ethical exploration of this innovative approach.

Starting school is exciting and for families managing T1D, a little planning can make all the difference.

We’re proud to announce that Stephanie Compton, PhD, a valued post‑doctoral researcher at the AdventHealth Research Institute, was recently featured by the American Cancer Society.

The adventHealth is excited to announce the launch of the SOMMA study. This study aims to better understand how our muscles and mobility function change as we age.

We are proud to announce the launch of the new RISE study.

Dr. Iswanto Sucandy was recently featured on AdventHealth West Florida Division’s “Team Talk” to discuss his groundbreaking textbook.

AdventHealth Research Institute’s new review, authored by Drs. Katie Whytock and Bret Goodpaster and published in Circulation Research, highlights how skeletal muscle regulates insulin and glucose...

On July 10, 2025, AdventHealth Director of Neuroscience Clinical Research Anita Fletcher, MD, worked with NKGen Biotech to administer the first dose of troculeucel (SNK01), an investigative natural...

In our latest Clinician’s View, Dr. Seminerio shares her personal passion for improving care for patients with inflammatory bowel disease (IBD) and talks about how AdventHealth’s recently established...